
0:00
13:29
This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
Mais episódios de "Two Onc Docs"



Não percas um episódio de “Two Onc Docs” e subscrevê-lo na aplicação GetPodcast.








